Clinical Trial Record

Return to Clinical Trials

The Emotional Impact of Surveillance for Pancreatic Cancer


2017-07-01


2021-07-31


2021-12-31


150

Study Overview

The Emotional Impact of Surveillance for Pancreatic Cancer

Due to its rarity a population screening program for pancreatic cancer is not possible. For this reason, considering background data on genetic predisposition and familiarity for this lethal tumor, efforts have been pushed to build up surveillance programs for subjects at high-risk of pancreatic cancer, due to familiarity and/or genetic predisposition. These programs are based on radiological examinations (such as MRI or endoultrasonography) and laboratory tests. However, little is known about the psychological burden of these programs. Only a handful of studies investigated, in various ways, how the participation in surveillance programs for pancreatic cancer may burden the psychological status, with a consequent possible impairment of the psychological wellbeing, and a higher risk of withdraw from the surveillance program itself. The aim of this study was to assess the psychological and emotional impact in high-risk individuals participating in a surveillance program for pancreatic cancer due to familiarity and/or to genetic predisposition, using specific psychological tools, such as multiple psychological questionnaires, investigating different functioning areas, administered by a clinical psychologist.

N/A

  • Pancreatic Cancer
  • Psychological Distress
  • DIAGNOSTIC_TEST: Barratt Simplified Measure of Social Status (BSMSS)
  • DIAGNOSTIC_TEST: Global Assessment of Functioning scale (GAF)
  • DIAGNOSTIC_TEST: General Self-Efficacy Scale (GSES)
  • DIAGNOSTIC_TEST: Perceived Stress Scale (PSS)
  • DIAGNOSTIC_TEST: Coping Orientation to Problems Experienced (Brief COPE),
  • DIAGNOSTIC_TEST: Multidimensional Scale of Perceived Social Support (MSPSS)
  • Psy-FPC

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2019-07-10  

N/A  

2020-03-30  

2019-07-16  

N/A  

2020-03-31  

2019-07-18  

N/A  

2020-03  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Diagnostic


Allocation:
Na


Interventional Model:
Single Group


Masking:
None


Arms and Interventions

Participant Group/ArmIntervention/Treatment
EXPERIMENTAL: Psychometric assessment group

Arms to whom the psychometric assessment will be administered

DIAGNOSTIC_TEST: Barratt Simplified Measure of Social Status (BSMSS)

  • Questionnaire that evaluates cultural identity, educational level and occupation of the subject and the subject's parents and spouse (if any)

DIAGNOSTIC_TEST: Global Assessment of Functioning scale (GAF)

  • Used to measure overall levels of functionality of an individual

DIAGNOSTIC_TEST: General Self-Efficacy Scale (GSES)

  • Psychometric scale that is designed to assess optimistic self-beliefs to cope with a variety of difficult demands in life

DIAGNOSTIC_TEST: Perceived Stress Scale (PSS)

  • To assess the perceived stress

DIAGNOSTIC_TEST: Coping Orientation to Problems Experienced (Brief COPE),

  • It evaluates the subject's coping style through investigation of problem-solving abilities and emotional fluctuation, as a response to stressful situations

DIAGNOSTIC_TEST: Multidimensional Scale of Perceived Social Support (MSPSS)

  • to explore the subject's social support system
Primary Outcome MeasuresMeasure DescriptionTime Frame
Barratt Simplified Measure of Social StatusEvaluation of cultural identity, educational level and occupation of the subject and the subject's parents and spouse (if any)Baseline
Barratt Simplified Measure of Social StatusEvaluation of cultural identity, educational level and occupation of the subject and the subject's parents and spouse (if any)2-years
Global Assessment of Functioning scalemeasure overall levels of functionality of an individualBaseline
Global Assessment of Functioning scalemeasure overall levels of functionality of an individual2-years
General Self-Efficacy ScaleSelf-report scale correlated to emotion, optimism, workBaseline
General Self-Efficacy ScaleSelf-report scale correlated to emotion, optimism, work2-years
Perceived Stress ScaleAssessment of the perceived stressBaseline
Perceived Stress ScaleAssessment of the perceived stress2-year
Coping Orientation to Problems Experiencedevaluation of the subject's coping style through investigation of problem-solving abilities and emotional fluctuation, as a response to stressful situationsBaseline
Coping Orientation to Problems Experiencedevaluation of the subject's coping style through investigation of problem-solving abilities and emotional fluctuation, as a response to stressful situations2-years
Multidimensional Scale of Perceived Social Supportto explore the subject's social support systemBaseline
Multidimensional Scale of Perceived Social Supportto explore the subject's social support system2-years
Secondary Outcome MeasuresMeasure DescriptionTime Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:

Accepts Healthy Volunteers:
1

    Inclusion Criteria:

  • Being enrolled in the Institutional surveillance program for pancreatic cancer
  • Ability to understand the details and implications of a study protocol.

  • Exclusion Criteria:

  • None

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Maheu C, Vodermaier A, Rothenmund H, Gallinger S, Ardiles P, Semotiuk K, Holter S, Thayalan S, Esplen MJ. Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning. Fam Cancer. 2010 Dec;9(4):617-24. doi: 10.1007/s10689-010-9354-5.
  • Konings IC, Harinck F, Kuenen MA, Sidharta GN, Kieffer JM, Aalfs CM, Poley JW, Smets EM, Wagner A, van Rens A, Vleggaar FP, Ausems MG, Fockens P, van Hooft JE, Bruno MJ, Bleiker EM; Dutch research group on pancreatic cancer surveillance in high-risk individuals. Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance. Fam Cancer. 2017 Jan;16(1):143-151. doi: 10.1007/s10689-016-9930-4.
  • Harinck F, Nagtegaal T, Kluijt I, Aalfs C, Smets E, Poley JW, Wagner A, van Hooft J, Fockens P, Bruno M, Bleiker EM. Feasibility of a pancreatic cancer surveillance program from a psychological point of view. Genet Med. 2011 Dec;13(12):1015-24. doi: 10.1097/GIM.0b013e31822934f5.
  • Konings IC, Sidharta GN, Harinck F, Aalfs CM, Poley JW, Kieffer JM, Kuenen MA, Smets EM, Wagner A, van Hooft JE, van Rens A, Fockens P, Bruno MJ, Bleiker EM. Repeated participation in pancreatic cancer surveillance by high-risk individuals imposes low psychological burden. Psychooncology. 2016 Aug;25(8):971-8. doi: 10.1002/pon.4047. Epub 2015 Dec 3.
  • Cazacu IM, Luzuriaga Chavez AA, Saftoiu A, Bhutani MS. Psychological impact of pancreatic cancer screening by EUS or magnetic resonance imaging in high-risk individuals: A systematic review. Endosc Ultrasound. 2019 Jan-Feb;8(1):17-24. doi: 10.4103/eus.eus_25_18.
  • Paiella S, Capurso G, Cavestro GM, Butturini G, Pezzilli R, Salvia R, Signoretti M, Crippa S, Carrara S, Frigerio I, Bassi C, Falconi M, Iannicelli E, Giardino A, Mannucci A, Laghi A, Laghi L, Frulloni L, Zerbi A. Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry. Am J Gastroenterol. 2019 Apr;114(4):665-670. doi: 10.1038/s41395-018-0414-z.